awmsg logo



sodium phenylbutyrate (Ammonaps®)


Reference No. 280

Publication date:
25/05/2004


Appraisal information

sodium phenylbutyrate (Ammonaps®) 500 mg tablet
sodium phenylbutyrate (Ammonaps®) 940 mg/g granules


Company: Orphan Europe (UK) Ltd
BNF category: Nutrition and blood
NMG meeting date: Not scheduled
AWMSG meeting date: 02/03/2004
   
   
Submission Type: Full Submission
Status: Recommended
Advice No: Not available
Ministerial ratification: 14/05/2004

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

The Minister for Health & Social Services has endorsed AWMSG's recommendation to support the treatment of neonates and children suffering from urea cycle disorders with sodium phenylbutyrate within NHS Wales in accordance with appropriate peer-reviewed guidelines.
Final Appraisal Recommendation (FAR)
Download